Abstract
Osteosarcoma is the 3rd most common human cancer in childhood and young adults, and is the leading cause of mortality. Recent studies suggest that miRNAs could regulate the growth and progression of osteosarcoma, indicating some novel targets for therapy. In our study, we demonstrated that miR-451 was down-regulated in human osteosarcoma U2OS, SAOS, and MG63 cells lines as well as in tumor tissue surgically resected compared with the normal tissues. Overexpression of miR-451 inhibited cell proliferation and resulted in cell apoptosis in osteosarcoma cells. G1 cell cycle arrest was also induced by miR-451. Repressed by miR-451, PGE2 and CCND1 reversed the inhibitory effects of miR-451 on proliferation. In conclusion, miR-451 played a tumor-suppressing role through modulating the expression of PGE2 and CCND1, suggesting a novel target for the diagnosis and treatment of osteosarcoma.
Similar content being viewed by others
References
Oshrine, B. R., Sullivan, L. M., & Balamuth, N. J. (2013). Ectopic production of beta-hCG by osteosarcoma: A case report and review of the literature. Journal of Pediatric Hematology/Oncology. doi:10.1097/MPH.0000000000000037.
Lauvrak, S. U., Munthe, E., Kresse, S. H., Stratford, E. W., Namlos, H. M., Meza-Zepeda, L. A., et al. (2013). Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes. British Journal of Cancer. doi:10.1038/bjc.2013.549.
Posthumadeboer, J., Piersma, S. R., Pham, T. V., van Egmond, P. W., Knol, J. C., Cleton-Jansen, A. M., et al. (2013). Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery. British Journal of Cancer. doi:10.1038/bjc.2013.578.
Osaki, M., Takeshita, F., Sugimoto, Y., Kosaka, N., Yamamoto, Y., Yoshioka, Y., et al. (2011). MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression. Molecular Therapy, 19(6), 1123–1130. doi:10.1038/mt.2011.53.
Zhang, H., Cai, X., Wang, Y., Tang, H., Tong, D., & Ji, F. (2010). microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2. Oncology Reports, 24(5), 1363–1369.
Camacho, L., Guerrero, P., & Marchetti, D. (2013). MicroRNA and protein profiling of brain metastasis competent cell-derived exosomes. PLoS One, 8(9), e73790. doi:10.1371/journal.pone.0073790.
Yang, Z., Yuan, Z., Fan, Y., Deng, X., & Zheng, Q. (2013). Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma. Molecular Medicine Reports, 8, 1353–1358. doi:10.3892/mmr.2013.1699.
Fu, X., Meng, Z., Liang, W., Tian, Y., Wang, X., Han, W., et al. (2013). miR-26a enhances miRNA biogenesis by targeting Lin28B and Zcchc11 to suppress tumor growth and metastasis. Oncogene. doi:10.1038/onc.2013.385.
Lin, S. H., Chong, Z. Z., & Maiese, K. (2001). Cell cycle induction in post-mitotic neurons proceeds in concert with the initial phase of programmed cell death in rat. Neuroscience Letters, 310(2–3), 173–177.
Dong, L., He, J. G., Shan, G. L., Lu, X. L., Zeng, W. J., Liu, Z. H., et al. (2012). Clinical analysis of 150 patients with idiopathic pulmonary arterial hypertension. Zhonghua xin xue guan bing za zhi., 40(8), 657–661.
Tian, Y., Nan, Y., Han, L., Zhang, A., Wang, G., Jia, Z., et al. (2011). MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma. International Journal of Oncology, 40(4), 1105–1112. doi:10.3892/ijo.2011.1306.
Jalali, M. T., Khosravi, M., Keikhaei, B., Dehuori, F., & Latifi, M. (2010). Evaluation of plasma activity level of anticoagulant proteins in patients with acute lymphoblastic leukemia in Shafa hospital Ahwaz. European Review for Medical and Pharmacological Sciences, 16(8), 1045–1051.
Timeus, F., Crescenzio, N., Doria, A., Foglia, L., Pagliano, S., Ricotti, E., et al. (2012). In vitro anti-neuroblastoma activity of saquinavir and its association with imatinib. Oncology Reports, 27(3), 734–740. doi:10.3892/or.2011.1582.
Leng, L., Huang, Q., Dong, Y., Yu, H., Tian, Y., & Peng, G. (2013). EZH2 gene silenced by siRNA suppresses the growth and invasion of endometrial carcinoma cells. Nan Fang Yi Ke Da Xue Xue Bao, 33(6), 866–869.
Xiong, C. M., Lu, X. L., Shan, G. L., Wu, B. X., Zhu, X. Y., Wu, G. H., et al. (2012). Oral sildenafil therapy for Chinese patients with pulmonary arterial hypertension: A multicenter study. Journal of Clinical Pharmacology, 52(3), 425–431. doi:10.1177/0091270011398241.
Li, H. Y., Zhang, Y., Cai, J. H., & Bian, H. L. (2013). MicroRNA-451 inhibits growth of human colorectal carcinoma cells via downregulation of Pi3k/Akt pathway. Asian Pacific Journal of Cancer Prevention, 14(6), 3631–3634.
Pan, X., Wang, R., & Wang, Z. X. (2013). The potential role of miR-451 in cancer diagnosis, prognosis, and therapy. Molecular Cancer Therapeutics, 12(7), 1153–1162. doi:10.1158/1535-7163.MCT-12-0802.
Chen, C. H., Chen, H. A., Wang, H. P., Liao, H. T., Chou, C. T., & Huang, D. F. (2006). Pulmonary arterial hypertension in autoimmune diseases: An analysis of 19 cases from a medical center in northern Taiwan. Journal of Microbiology, Immunology, and Infection = Wei mian yu gan ran za zhi., 39(2), 162–168.
Kim, Y., Roh, S., Lawler, S., & Friedman, A. (2011). miR451 and AMPK mutual antagonism in glioma cell migration and proliferation: A mathematical model. PLoS One, 6(12), e28293. doi:10.1371/journal.pone.0028293.
Aubert, B., Bona, M., Karyotakis, Y., Lees, J. P., Poireau, V., Prencipe, E., et al. (2008). Searches for B meson decays to phiphi, phirho, phif_{0}(980), and f_{0}(980)f_{0}(980) final states. Physical Review Letters, 101(20), 201801.
Aubert, B., Bona, M., Karyotakis, Y., Lees, J. P., Poireau, V., Prencipe, E., et al. (2008). Observation and polarization measurements of B ± → phiK1 ± and B ± → phiK2 *±. Physical Review Letters, 101(16), 161801.
Bronner, M. P., O’Sullivan, J. N., Rabinovitch, P. S., Crispin, D. A., Chen, L., Emond, M. J., et al. (2008). Genomic biomarkers to improve ulcerative colitis neoplasia surveillance. The American Journal of Pathology, 173(6), 1853–1860. doi:10.2353/ajpath.2008.080250.
Ju, X., Li, D., Shi, Q., Hou, H., Sun, N., & Shen, B. (2009). Differential microRNA expression in childhood B-cell precursor acute lymphoblastic leukemia. Pediatric Hematology and Oncology, 26(1), 1–10. doi:10.1080/08880010802378338.
Bonfrate, L., Altomare, D. F., Di Lena, M., Travaglio, E., Rotelli, M. T., De Luca, A., et al. (2013). MicroRNA in colorectal cancer: New perspectives for diagnosis, prognosis and treatment. Journal of Gastrointestinal and Liver Diseases, 22(3), 311–320.
Xu, J., Zhang, R., Shen, Y., Liu, G., Lu, X., & Wu, C. I. (2013). The evolution of evolvability in microRNA target sites in vertebrates. Genome Research, 23, 1810–1816. doi:10.1101/gr.148916.112.
Aubert, B., Bona, M., Boutigny, D., Karyotakis, Y., Lees, J. P., Poireau, V., et al. (2008). Observation of B^{0} → K^{* 0} K [over¯]^{* 0} and search for B^{0} → K^{* 0} K^{* 0}. Physical Review Letters, 100(8), 081801.
Ji, F., Zhang, H., Wang, Y., Li, M., Xu, W., Kang, Y., et al. (2013). MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1. Bone, 56(1), 220–226. doi:10.1016/j.bone.2013.05.020.
Won, K. Y., Kim, Y. W., Kim, H. S., Lee, S. K., Jung, W. W., & Park, Y. K. (2013). MicroRNA-199b-5p is involved in the notch signaling pathway in osteosarcoma. Human Pathology, 44(8), 1648–1655. doi:10.1016/j.humpath.2013.01.016.
Yuan, J., Chen, L., Chen, X., Sun, W., & Zhou, X. (2012). Identification of serum microRNA-21 as a biomarker for chemosensitivity and prognosis in human osteosarcoma. Journal of International Medical Research, 40(6), 2090–2097.
Zhao, H., Guo, M., Zhao, G., Ma, Q., Ma, B., Qiu, X., et al. (2012). miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells. International Journal of Molecular Medicine, 30(5), 1013–1020. doi:10.3892/ijmm.2012.1111.
Zhu, J., Feng, Y., Ke, Z., Yang, Z., Zhou, J., Huang, X., et al. (2012). Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin. The American Journal of Pathology, 180(6), 2440–2451. doi:10.1016/j.ajpath.2012.02.023.
Fan, L., Wu, Q., Xing, X., Wei, Y., & Shao, Z. (2012). MicroRNA-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of osteosarcoma cells. Acta Biochimica et Biophysica Sinica (Shanghai), 44(5), 407–414. doi:10.1093/abbs/gms019.
Li, H. P., Zeng, X. C., Zhang, B., Long, J. T., Zhou, B., Tan, G. S., et al. (2013). miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-beta. Carcinogenesis, 34, 2443–2451. doi:10.1093/carcin/bgt206.
Giantin, M., Vascellari, M., Lopparelli, R. M., Ariani, P., Vercelli, A., Morello, E. M., et al. (2012). Expression of the aryl hydrocarbon receptor pathway and cyclooxygenase-2 in dog tumors. Research in Veterinary Science, 94(1), 90–99. doi:10.1016/j.rvsc.2012.07.035.
Millanta, F., Asproni, P., Cancedda, S., Vignoli, M., Bacci, B., & Poli, A. (2012). Immunohistochemical expression of COX-2, mPGES and EP2 receptor in normal and reactive canine bone and in canine osteosarcoma. Journal of Comparative Pathology, 147(2–3), 153–160. doi:10.1016/j.jcpa.2012.02.003.
Coetzee, M., Haag, M., Claassen, N., & Kruger, M. C. (2005). Stimulation of prostaglandin E2 (PGE2) production by arachidonic acid, oestrogen and parathyroid hormone in MG-63 and MC3T3-E1 osteoblast-like cells. Prostaglandins Leukotrienes and Essential Fatty Acids, 73(6), 423–430. doi:10.1016/j.plefa.2005.08.005.
Brechter, A. B., & Lerner, U. H. (2002). Characterization of bradykinin receptors in a human osteoblastic cell line. Regulatory Peptides, 103(1), 39–51.
Conflict of interest
The authors have on conflicts of interest to declare.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Haidong Xu and Qiang Mei have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Xu, H., Mei, Q., Shi, L. et al. Tumor-Suppressing Effects of miR451 in Human Osteosarcoma. Cell Biochem Biophys 69, 163–168 (2014). https://doi.org/10.1007/s12013-013-9783-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-013-9783-5